Brain region- and sex-specific modulation of mitochondrial glucocorticoid receptor phosphorylation in fluoxetine treated stressed rats: Effects on energy metabolism

Psychoneuroendocrinology

Volumn 38, Issue 12, 2013, Pages 2914-2924

  Adzic, Miroslav ^a   Lukic, Iva ^a   Mitic, Milos ^a   Djordjevic, Jelena ^a   Elaković, Ivana ^b   Djordjevic, Ana ^b   Krstic Demonacos, Marija ^c   Matić, Gordana ^b   Radojcic, Marija ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF SALFORD   (United Kingdom)

Author keywords

Chronic stress; Fluoxetine; Gender; Glucocorticoid receptor phosphorylation; Hippocampus; Mitochondria; Prefrontal cortex

Indexed keywords

CYTOCHROME; CYTOCHROME C OXIDASE; FLUOXETINE; GLUCOCORTICOID RECEPTOR; MITOCHONDRIAL GLUCOCORTICOID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CHRONIC STRESS; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HIPPOCAMPUS; MALE; METABOLIC PARAMETERS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

CHRONIC STRESS; FLUOXETINE; GENDER; GLUCOCORTICOID RECEPTOR PHOSPHORYLATION; HIPPOCAMPUS; MITOCHONDRIA; PREFRONTAL CORTEX;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOTTING, WESTERN; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; ESTROUS CYCLE; FEMALE; FLUOXETINE; HIPPOCAMPUS; MALE; MITOCHONDRIA; PHOSPHORYLATION; PREFRONTAL CORTEX; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; RNA; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TRANSCRIPTION, GENETIC;

EID: 84888287050     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.07.019     Document Type: Article

References (50)

1. Abdel-Razaq W., Kendall D., Bates T. The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria. Neurochem. Res. 2011, 36:327-338.
2. Adzic M., Djordjevic A., Demonacos C., Krstic-Demonacos M., Radojcic M.B. The role of phosphorylated glucocorticoid receptor in mitochondrial functions and apoptotic signalling in brain tissue of stressed Wistar rats. Int. J. Biochem. Cell Biol. 2009, 41:2181-2188.
3. Aguiar A.S., Tuon T., Pinho C.A., Silva L.A., Andreazza A.C., Kapczinski F., Quevedo J., Streck E.L., Pinho R.A. Mitochondrial IV complex and brain neurothrophic derived factor responses of mice brain cortex after downhill training. Neurosci. Lett. 2007, 426(3):171-174.
4. Alesci S., Manoli I., Michopoulos V., Brouwers F., Le H., Gold P., Blackman M., Rennert O., Su Y., Chrousos G. Development of a human mitochondria-focused cDNA microarray (hMitChip) and validation in skeletal muscle cells: implications for pharmaco-and mitogenomics. Pharmacogenomics J. 2006, 6:333-342.
5. Brack K., Jeffery S., Lovick T. Cardiovascular and respiratory responses to a panicogenic agent in anaesthetised female Wistar rats at different stages of the oestrous cycle. Eur. J. Neurosci. 2006, 23:3309-3318.
6. Capaldi R.A. Structure and function of cytochrome c oxidase. Annu. Rev. Biochem. 1990, 59:569-596.
7. Carlsson M., Carlsson A. A regional study of sex differences in rat brain serotonin. Prog. Neuropsychopharmacol. Biol. Psychiatry 1988, 12:53-61.
8. Chen J.Q., Yager J.D., Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim. Biophys. Acta 2005, 1746:1-17.
9. Chopra K., Kumar B., Kuhad A. Pathobiological targets of depression. Expert Opin. Ther. Targets 2011, 15:379-400.
10. Davies L., Karthikeyan N., Lynch J.T., Sial E.A., Gkourtsa A., Demonacos C., Krstic-Demonacos M. Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function. Mol. Endocrinol. 2008, 22:1331-1344.
11. Deicken R.F., Fein G., Weiner M.W. Abnormal frontal lobe phosphorous metabolism in bipolar disorder. Am. J. Psychiatry 1995, 152(6):915-918.
12. Demonacos C.V., Karayanni N., Hatzoglou E., Tsiriyiotis C., Spandidos D.A., Sekeris C.E. Mitochondrial genes as sites of primary action of steroid hormones. Steroids 1996, 61:226-232.
13. Djordjevic S., Kovacevic I., Miljkovic B., Vuksanovic J., Pokrajac M. Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: application to clinical study. Farmaco 2005, 60:345-349.
14. El Idrissi A., Trenkner E. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J. Neurosci. 1999, 19:9459-9468.
15. Fiigiel M., Engele J. Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism. J. Neurosci. 2000, 20:3596-3605.
16. Gardner A., Boles R.G. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:730-743.
17. Guidotti G., Calabrese F., Anacker C., Racagni G., Pariante C.M., Riva M.A. Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology 2013, 38:616-627.
18. Hroudova J., Fisar Z. Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuro Endocrinol. Lett. 2010, 31(3):336-342.
19. Huttemann M., Helling S., Sanderson T.H., Sinkler C., Samavati L., Mahapatra G., Varughese A., Lu G., Liu J., Ramzan R. Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation. Biochim. Biophys. Acta 2012, 1817:598-609.
20. Ismaili N., Garabedian M.J. Modulation of glucocorticoid receptor function via phosphorylation. Ann. N. Y. Acad. Sci. 2004, 1024:86-101.
21. Kato T., Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2008, 2:180-190.
22. Kennedy S.H., Evans K.R., Krüger S., Mayberg H.S., Meyer J.H., McCann S., Arifuzzman A.I., Houle S., Vaccarino F.J. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am. J. Psychiatry 2001, 158(6):899-905.
23. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 2004, 61:300-308.
24. Kornstein S.G., Schatzberg A.F., Thase M.E., Yonkers K.A., McCullough J.P., Keitner G.I., Gelenberg A.J., Ryan C.E., Hess A.L., Harrison W., Davis S.M., Keller M.B. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am. J. Psychiatry 2000, 157:1445-1452.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
26. Liang H., Ongwijitwat S., Wong-Riley M. Bigenomic functional regulation of all 13 cytochrome c oxidase subunit transcripts in rat neurons in vitro and in vivo. Neuroscience 2006, 140:177-190.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T))method. Methods 2001, 25:402-408.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
29. Mällo T., Matrov D., Kõiv K., Harro J. Effect of chronic stress on behavior and cerebral oxidative metabolism in rats with high or low positive affect. Neuroscience 2009, 164:963-974.
30. Manoli I., Alesci S., Blackman M.R., Yan, Su A., Owen M.R., Chrousos G.P. Mitochondria as key components of the stress response. Trends Endocrinol. Metab. 2007, 18:190-198.
31. Marcus S.M., Young E.A., Kerber K.B., Kornstein S., Farabaugh A.H., Mitchell J., Wisniewski S.R., Balasubramani G.K., Trivedi M.H., Rush A.J. Gender differences in depression: findings from the STAR*D study. J. Affect. Disord. 2005, 87:141-150.
32. Mitic M., Simic I., Djordjevic J., Radojcic M.B., Adzic M. Gender-specific effects of fluoxetine on hippocampal glucocorticoid receptor phosphorylation and behavior in chronically stressed rats. Neuropharmacology 2013, 70:100-111.
33. Moretti A., Gorini A., Villa R. Affective disorders, antidepressant drugs and brain metabolism. Mol. Psychiatry 2003, 8:773-785.
34. Moutsatsou P., Psarra A.M.G., Tsiapara A., Paraskevakou H., Davaris P., Sekeris C. Localization of the glucocorticoid receptor in rat brain mitochondria. Arch. Biochem. Biophys. 2001, 386:69-78.
35. O'Reilly K.C., Shumake J., Bailey S.J., Gonzalez-Lima F., Lane M.A. Chronic 13-cis-retinoic acid administration disrupts network interactions between the raphe nuclei and the hippocampal system in young adult mice. Eur. J. Pharmacol. 2009, 605:68-77.
36. Pitman D.L., Ottenweller J.E., Natelson B.H. Plasma corticosterone levels during repeated presentation of two intensities of restraint stress: chronic stress and habituation. Physiol. Behav. 1988, 43:47-55.
37. Quitkin F.M., Stewart J.W., McGrath P.J., Taylor B.P., Tisminetzky M.S., Petkova E., Chen Y., Ma G., Klein D.F. Are there differences between women's and men's antidepressant responses?. Am. J. Psychiatry 2002, 159:1848-1854.
38. Rubinow D.R., Schmidt P.J., Roca C.A. Estrogen-serotonin interactions: implications for affective regulation. Biol. Psychiatry 1998, 44:839-850.
39. Rustin P., Chretien D., Bourgeron T., Gerard B., Rotig A., Saudubray J., Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 1994, 228:35-51.
40. Rutledge R., Cote C. Mathematics of quantitative kinetic PCR and the application of standard curves. Nucleic Acids Res. 2003, 31:e93.
41. Sakata J.T., Crews D., Gonzalez-Lima F. Behavioral correlates of differences in neural metabolic capacity. Brain Res. Rev. 2005, 48:1-15.
42. Scaglia F. The role of mitochondrial dysfunction in psychiatric disease. Dev. Disabil. Res. Rev. 2010, 16:136-143.
43. Sheehan T.E., Kumar P.A., Hood D.A. Tissue-specific regulation of cytochrome c oxidase subunit expression by thyroid hormone. Am. J. Physiol. Endocrinol. Metab. 2004, 286(6):968-974.
44. Simoes D.C.M., Psarra A.M.G., Mauad T., Pantou I., Roussos C., Sekeris C.E., Gratziou C. Glucocorticoid and estrogen receptors are reduced in mitochondria of lung epithelial cells in asthma. PLoS ONE 2012, 7:e39183.
45. Sloan D.M., Kornstein S.G. Gender differences in depression and response to antidepressant treatment. Psychiatr. Clin. N. Am. 2003, 26:581-594.
46. Tagliari B., Noschang C.G., Ferreira A.G.K., Ferrari O.A., Feksa L.R., Wannmacher C.M.D., Dalmaz C., Wyse A.T.S. Chronic variable stress impairs energy metabolism in prefrontal cortex and hippocampus of rats: prevention by chronic antioxidant treatment. Metab. Brain Dis. 2010, 25:169-176.
47. Vaynman S., Ying Z., Wu A., Gomez-Pinilla F. Coupling energy metabolism with a mechanism to support brain-derived neurotrophic factor mediated synaptic plasticity. Neuroscience 2006, 4:1221-1234.
48. Warden D., Rush A.J., Trivedi M.H., Fava M., Wisniewski S.R. The STAR*D project results: a comprehensive review of findings. Curr. Psychiatry Rep. 2007, 9:449-459.
49. Wong-Riley M. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 1989, 12:94-101.
50. Yang S.J., Kim S.Y., Stewart R., Kim J.M., Shin I.S., Jung S.W., Lee M.S., Jeong S.H., Jun T.Y. Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: the CRESCEND study. Psychiatry Res. 2011, 189(1):82-90.